27-11-2019, 15:05
(This post was last modified: 27-11-2019, 15:06 by hibeejim21.)
The greater population won't care - they see things in simple soundbites like 'get Brexit done' and 'keep out corbyn'
The key part in the document is :
"USTR were also clear that the UK-EU situation would be determinative: there would be all to play for in a no deal situation, but UK commitment to the customs union and single market would make a US-UK FTA a non-starter".
Drug patenting in the USA is vastly more expensive than the UK.
As corbyn points out :
'In fact, negotiations have advanced even further than we feared they had. The US and UK have already finished initial discussion on lengthening patents for medicines.
Longer patents mean only one thing – more expensive drugs. Lives will be put at risk as a result of this.
Many out-of-patent medicines available cheaply here are vastly more expensive under patent law in the US.
The drug Humira for Crohn’s disease and rheumatoid arthritis costs our NHS £1,409 a packet. In the US, the same packet costs £8,115. Get the difference – £1,409 in our NHS, £8,115 in the USA.
One of the reasons for US drug prices being on average 250% higher than of those here is a patent regime rigged for the big pharmaceutical companies ...
If you look at the readout of the second meeting, on page 51, UK officials report that “patent issues” around “NHS access to generic drugs will be a key consideration” in talks.
The US want a no deal Brexit so they and their pals like Farage,banks and the ERG can get very rich off the back of sell offs like this.
The key part in the document is :
"USTR were also clear that the UK-EU situation would be determinative: there would be all to play for in a no deal situation, but UK commitment to the customs union and single market would make a US-UK FTA a non-starter".
Drug patenting in the USA is vastly more expensive than the UK.
As corbyn points out :
'In fact, negotiations have advanced even further than we feared they had. The US and UK have already finished initial discussion on lengthening patents for medicines.
Longer patents mean only one thing – more expensive drugs. Lives will be put at risk as a result of this.
Many out-of-patent medicines available cheaply here are vastly more expensive under patent law in the US.
The drug Humira for Crohn’s disease and rheumatoid arthritis costs our NHS £1,409 a packet. In the US, the same packet costs £8,115. Get the difference – £1,409 in our NHS, £8,115 in the USA.
One of the reasons for US drug prices being on average 250% higher than of those here is a patent regime rigged for the big pharmaceutical companies ...
If you look at the readout of the second meeting, on page 51, UK officials report that “patent issues” around “NHS access to generic drugs will be a key consideration” in talks.
The US want a no deal Brexit so they and their pals like Farage,banks and the ERG can get very rich off the back of sell offs like this.